R. Ciftci Et Al. , "Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer," Journal of Oncological Science , vol.2, no.1, pp.7-11, 2016
Ciftci, R. Et Al. 2016. Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer. Journal of Oncological Science , vol.2, no.1 , 7-11.
Ciftci, R., Taş, F., Bilgin, E., Keskin, S., Yildiz, I., Duranyildiz, D., ... Saip, P.(2016). Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer. Journal of Oncological Science , vol.2, no.1, 7-11.
Ciftci, Rumeysa Et Al. "Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer," Journal of Oncological Science , vol.2, no.1, 7-11, 2016
Ciftci, Rumeysa Et Al. "Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer." Journal of Oncological Science , vol.2, no.1, pp.7-11, 2016
Ciftci, R. Et Al. (2016) . "Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer." Journal of Oncological Science , vol.2, no.1, pp.7-11.
@article{article, author={Rumeysa Ciftci Et Al. }, title={Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancer}, journal={Journal of Oncological Science}, year=2016, pages={7-11} }